Evaluation of patients whose HCV serology was investigated in our hospital between 2010-2018
暂无分享,去创建一个
[1] H. Köseoğlu,et al. Physician awareness of hepatitis C virus among different departments , 2020, Clinical and experimental hepatology.
[2] C. Silvestri,et al. Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination , 2020, SN Comprehensive Clinical Medicine.
[3] D. Mert,et al. Hepatitis C screening and referral for further investigation and treatment in a tertiary care hospital. , 2020, Journal of infection in developing countries.
[4] E. Tigen,et al. Chronic Hepatitis C Prevalence, Genotype Distribution and Treatment Responses at Marmara University Pendik Training and Research Hospital Between 2014-2018 , 2020 .
[5] N. Tunc. Chronic Hepatitis C Prevalence and Physician Awareness in Southeastern Turkey , 2019 .
[6] F. Ateş,et al. Patients Lost after Anti-HCV-Positive Finding in a Tertiary Care University Hospital: Increased Awareness and Action is Necessary to Eradicate HCV , 2019, Sisli Etfal Hastanesi tip bulteni.
[7] Sanjeev Arora,et al. The ECHO model proved to be a useful tool to increase clinicians' self‐effectiveness for care of patients with Hepatitis C in Argentina , 2019, Journal of viral hepatitis.
[8] M. Ağın,et al. Chronic hepatitis C infection: how much are physicians aware of? , 2019, Przeglad gastroenterologiczny.
[9] D. Turan,et al. Seroprevalence of HBsAg and anti-HCV for patients who admitted to third step hospital: Six-year retrospective data , 2019 .
[10] N. Terrault. Hepatitis C elimination: challenges with under-diagnosis and under-treatment , 2019, F1000Research.
[11] J. Ward,et al. The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals , 2019, Journal of virus eradication.
[12] F. Chisari,et al. Is Elimination of Hepatitis B and C a Pipe Dream or Reality? , 2019, Gastroenterology.
[13] Jean-Michel Pawlotsky,et al. EASL Recommendations on Treatment of Hepatitis C 2018. , 2018, Journal of hepatology.
[14] J. Ward,et al. Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework , 2018, Journal of virus eradication.
[15] F. Chisari,et al. Is Elimination of Hepatitis B and C a Pipe Dream or Reality? , 2018, Gastroenterology.
[16] U. Akarca,et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[17] J. Feld,et al. Hepatitis C virus infection , 2015, Canadian Medical Association Journal.
[18] O. Karadag,et al. Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital , 2014 .
[19] J. Ward,et al. Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward) , 2014, Journal of viral hepatitis.
[20] Lai Wei,et al. Inadequate awareness of hepatitis C among nonspecialist physicians in China , 2011, Advances in medical education and practice.
[21] Ş. Şahin,et al. Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study. , 2009, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.